{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:57:59Z","timestamp":1765886279644,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.canrad.2020.05.025","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T15:24:19Z","timestamp":1609601059000},"page":"32-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and dosimetric impact of totally implantable venous access devices in radiotherapy of supra diaphragmatic Hodgkin Lymphoma"],"prefix":"10.1016","volume":"25","author":[{"given":"M.","family":"Laurans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kirov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.M.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2020.05.025_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.6004\/jnccn.2018.0013","article-title":"NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018","volume":"16","author":"Hoppe","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.canrad.2020.05.025_bib0070","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1399-6576.2008.01664.x","article-title":"Peripheral intravenous catheter use in Europe: towards the use of safety devices: IVCs in Europe","volume":"52","author":"Strauss","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.canrad.2020.05.025_bib0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.suronc.2012.02.003","article-title":"Update on totally implantable venous access devices","volume":"21","author":"Zaghal","year":"2012","journal-title":"Surg Oncol"},{"key":"10.1016\/j.canrad.2020.05.025_bib0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.radonc.2015.04.016","article-title":"Implantable drug delivery systems should be inserted outside radiation therapy fields in breast cancer patients","volume":"115","author":"Cao","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.05.025_bib0085","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.2003.03.023","volume":"21","author":"Engert","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.05.025_bib0090","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG)","volume":"89","author":"Specht","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.05.025_bib0095","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150409","article-title":"Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literature","volume":"89","author":"Besson","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2020.05.025_bib0100","first-page":"2","article-title":"Can we reduce the toxicity of the mediastinal irradiation using new highly conformal techniques?","volume":"2","author":"Pernin","year":"2014","journal-title":"J Leuk"},{"key":"10.1016\/j.canrad.2020.05.025_bib0105","article-title":"Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT)","volume":"10","year":"2010","journal-title":"J ICRU"},{"key":"10.1016\/j.canrad.2020.05.025_bib0110","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0360-3016(98)00239-9","article-title":"Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index","volume":"42","author":"Knoos","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.05.025_bib0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.05.025_bib0120","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0360-3016(02)04599-6","article-title":"Quantifying the degree of conformity in radiosurgery treatment planning","volume":"55","author":"Lomax","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820303267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820303267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:32:19Z","timestamp":1761136339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321820303267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1278321820303267"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2020.05.025","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and dosimetric impact of totally implantable venous access devices in radiotherapy of supra diaphragmatic Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2020.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}